The Feasibility of a Radiological Score Based on CT Signs for Recognizing Salvageable Bowel in Acute Mesenteric Ischemia

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Tartu

About this trial

Computed tomography (CT) is the standard modality for scanning patients with critical acute abdominal conditions, including suspected acute mesenteric ischemia (AMI). CT imaging can potentially differentiate between reversible and irreversible ischaemic damage of the bowel. This moment is pivotal in selecting the treatment strategy for AMI - in the absence of irreversible damage; reperfusion therapy can preserve intestinal viability, thereby avoiding the need for bowel resection. The present study tests the hypothesis that combining several symptoms may enhance the diagnostic performance of CT scanning in detecting salvageable bowel in patients with AMI. This study is an ancillary component of the AMESI study (Clinical Trials: NCT05218863) - a prospective, multicentre observational study aimed at identifying the incidence and describing the outcomes of acute mesenteric ischemia (AMI) in adult hospitalized patients. The ultimate purpose of the present study is to create a computed tomography-based radiological score for the assessment of bowel viability in patients with AMI.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Participant in AMESI study

confirmed or suspected acute mesenteric ischaemia

CT scan of the entire abdominal cavity / full body using intravenous contrast media is available

Disqualifiers

Scans without the use of an intravenous contrast media or those covering only a partial area of the abdomen will be excluded.

Trial population

This is a substudy of the AMESI study - "Incidence, Diagnosis, Management, and Outcome of Acute Mesenteric Ischaemia: A Prospective, Multicentre Observational Study." (Clinical Trials: NCT05218863) As of the end of August 2023, a total of 705 patients from 32 study sites worldwide have been enrolled, with 418 of them having confirmed cases of AMI. For patients with confirmed AMI, comprehensive data collection concerning diagnostics, management, and long-term outcomes has been completed

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

200 Participants
are grouped into 3 trial groups
Group A: Controls
Group B: AMI patients with salvageable bowel
Group C: AMI patients with non-salvageable bowel

Trial outcomes

Primary outcomes

1

Frequency rate

Frequency rate of common radiological signs in AMI patients with and without salvageable bowel.

Time frame
up to one month

Secondary outcomes

1

Performance of the radiological score

Performance of the radiological score in patients with different types of AMI.

Time frame
up to one month

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.